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Poxvirus replication involves synthesis of double-
stranded RNA (dsRNA), which can trigger antiviral
responses by inducing phosphorylation-mediated
activation of protein kinase R (PKR) and stimulating
2050-oligoadenylate synthetase (OAS). PKR inacti-
vates the translation initiation factor eIF2a via phos-
phorylation, while OAS induces the endonuclease
RNase L to degrade RNA. We show that poxvirus de-
capping enzymes D9 and D10, which remove caps
from mRNAs, inhibit these antiviral responses by
preventing dsRNA accumulation. Catalytic sitemuta-
tions of D9 and D10, but not of either enzyme alone,
halt vaccinia virus late protein synthesis and inhibit
virus replication. Infection with the D9-D10 mutant
was accompanied by massive mRNA reduction,
cleavage of ribosomal RNA, and phosphorylation of
PKR and eIF2a that correlated with a 15-fold in-
crease in dsRNA compared to wild-type virus. Addi-
tionally, mouse studies show extreme attenuation
of the mutant virus. Thus, vaccinia virus decapping,
in addition to targeting mRNAs for degradation, pre-
vents dsRNA accumulation and anti-viral responses.
INTRODUCTION
Two remarkable and seemingly unrelated properties of poxvi-
ruses are the encoding of decapping enzymes that hydrolyze
the 50cap of mRNA (Parrish and Moss, 2007; Parrish et al.,
2007) and the synthesis of viral complementary or double-
stranded RNA (dsRNA) (Boone et al., 1979; Colby and Duesberg,
1969), which is a potent inducer of innate antiviral response path-
ways (Silverman, 2007). Here we show that inactivation of the
vaccinia virus (VACV) decapping enzymes leads to a huge in-
crease in dsRNAwith a devastating effect on viral protein synthe-
sis and replication in infected cells and severe attenuation in
mice.
Eukaryotic mRNAs typically possess a cap at the 50 end (Fur-
uichi et al., 1975; Wei et al., 1975) and poly(A) at the 30 end (Ed-
monds et al., 1971), both of which are important for stability and
translation. Enzymes with nudix hydrolase motifs that decap
mRNA are present in yeast andmammalian cells and are thought320 Cell Host & Microbe 17, 320–331, March 11, 2015 ª2015 Elsevieto function in mRNA decay (Dunckley and Parker, 1999; Wang
et al., 2002). mRNA decay begins with shortening of the poly(A)
tail and proceeds in either the 50-to-30 or 30-to-50 direction (Gar-
neau et al., 2007). In the 50-to-30 pathway, removal of the cap is
followed by exoribonuclease Xrn1 digestion (Hsu and Stevens,
1993).
Poxviruses are double-stranded DNA viruses that replicate
and transcribe their genomes and assemble infectious particles
exclusively in the cytoplasm of cells (Moss, 2013). Like eukary-
otes, poxviruses encode enzymes that cap and methylate the
50 ends of mRNA (Barbosa and Moss, 1978; Martin et al.,
1975; Wei and Moss, 1975) and add adenylate residues to the
30 ends (Gershon et al., 1991; Moss et al., 1973) as well as en-
zymes with nudix hydrolase motifs that specifically degrade
methylated cap structures on RNAs (Parrish and Moss, 2007;
Parrish et al., 2007). In fact, VACV, the prototype poxvirus, en-
codes two decapping enzymes, D9 and D10, with 25% pre-
dicted amino acid identity. Homologs of D10 are conserved in
all poxviruses, and homologs of D9 are present in members of
most vertebrate poxvirus genera (Upton et al., 2003), suggesting
their importance. Gene expression is sequentially regulated dur-
ing VACV infection (Baldick and Moss, 1993; Yang et al., 2010).
Synthesis of the D9 decapping enzyme begins early in infection
whereas D10 is only made following viral DNA replication, sug-
gesting roles throughout the VACV cycle. Ribosome profiling
indicated that D9 continues to be synthesized at late times
(Z. Yang and B.M., unpublished data). No evidence for interac-
tion of D9 and D10 was obtained by affinity purification (S. Par-
rish and B.M., unpublished data). Decapping enzymes may
accelerate degradation of cellular mRNA to minimize the host
response to virus infection and reduce competition with viral
mRNAs for the translation machinery. Shortening the half-life of
viral mRNAs might also sharpen the division between the early,
intermediate, and late phases of virus replication. Yet mutagen-
esis of D9 had no effect on VACV replication, andmutagenesis of
D10 had amodest effect on enhancing the stability of cellular and
viral mRNA and reducing virulence in a mouse infection model
(Liu et al., 2014; Parrish and Moss, 2006). Nevertheless, efforts
to delete both D9 and D10 and propagate such mutants proved
difficult, suggesting that they have an essential but redundant
function (Parrish and Moss, 2006).
We have now succeeded in constructing and isolating VACV
with inactivating mutations in the catalytic sites of both D9 and
D10. The double mutant, called vD9muD10mu, has a replication
defect in customarily used human and monkey cell lines, which
accounts for our initial inability to isolate the mutant. Synthesisr Inc.
of early mRNAs and proteins and genome replication occurred
normally in non-permissive cells. However, subsequent to the
onset of viral late transcription there was an abrupt decrease in
the amount of late mRNAs and diminished late protein synthesis.
These events were accompanied by cleavage of 28S and 18S
rRNA, a signature of RNase L activation (Silverman et al.,
1983), and phosphorylation of protein kinase R (PKR), eIF2a,
and IRF3. These findings suggested a role for dsRNA, which
activates innate antiviral pathways and leads to inhibition of pro-
tein synthesis (Perdiguero and Esteban, 2009; Silverman, 2007;
Stark et al., 1998). Indeed, we found a large accumulation of
dsRNA in cells infected with the double mutant. Since only the
catalytic sites of D9 and D10 were inactivated, we concluded
that an important role of decapping, in addition to enhancing
decay of host and viral mRNAs, is to prevent dsRNA from form-
ing or to accelerate its degradation.
RESULTS
Host-Range Restriction of Catalytic Site Mutants
In previous studies, we mutated the decapping enzymes of
VACV individually and found only modest effects on virus repli-
cation (Liu et al., 2014; Parrish and Moss, 2006). The object of
the present study was to determine the effects of inactivating
both decapping enzymes in the same virus. Point mutations in
the nudix hydrolase motifs of D9 and D10, which were previously
shown to completely inactivate decapping activity in vitro (Par-
rish and Moss, 2007; Parrish et al., 2007), were made. The
VACV mutant vD9mu with catalytic site mutations in D9 and
the double mutant vD9muD10mu were constructed by homolo-
gous recombination for the present study (Figure 1A). The VACV
mutant vD10mu, with catalytic site mutations in D10 and the
revertant vD10rev control virus, which has wild-type (WT) D9
and WT D10, were previously described (Liu et al., 2014).
Initial studies indicated that each of the viruses including
vD9muD10mu replicated in baby hamster kidney-21 (BHK-21)
cells, and therefore these cells were used to prepare stocks of
mutant and WT viruses.
The abilities of the mutant viruses to form plaques in African
green monkey BS-C-1, human HeLa, mouse embryonic fibro-
blast (MEF), and hamster BHK-21 cells are shown in Figure 1B.
WT, vD10rev, and vD9mu formed plaques that were similar to
each other in the four cell lines. Relative plaque sizes were BS-
C-1 > BHK-21 > HeLazMEF. The vD10mu virus formed plaques
slightly smaller than WT in HeLa cells. Although the sizes of the
plaques formed by vD9muD10mu approached those of WT virus
in BHK-21 andMEF cells, they were barely detectable in BS-C-1
and HeLa cells. Thus, vD9muD10mu exhibited a severe host
range phenotype.
Since plaque formation depends on cell-to-cell spread as well
as virus replication, we carried out one-step growth experiments
to distinguish between these events. The yields of vD9mu and
vD10mu were equivalent to that of WT and the vD10rev in BS-
C-1, HeLa, BHK-21, and MEF cells. In contrast, the yields of
vD9muD10mu were similar or only slightly lower than the others
in BHK-21 andMEF cells but two to three logs lower in HeLa and
BS-C-1 cells (Figure 1C). Thus, the data obtained from plaque
formation and virus yields indicated that the double mutant
had a severe replication defect in BS-C-1 and HeLa cells butCell Honot in BHK-21 or MEF cells. The host range restriction of
vD9muD10mu extended to African green monkey VERO, human
MRC-5, and human A549 cells, whereas moderate replication
occurred in rabbit kidney-13 (RK-13) cells and chicken embryo
fibroblasts (not shown).
The low replication of vD9muD10mu in non-permissive cells
could be due to an inability to form virus particles or to the forma-
tion of virions that lack infectivity. To visualize viral structures,
permissive BHK-21 and non-permissive BS-C-1 cells were in-
fected with the panel of mutant and WT viruses and examined
by transmission electron microscopy. The vD9mu, vD10mu,
vD10rev, andWT viruses produced immature andmature virions
in both BHK-21 and BS-C-1 cells consistent with their abilities
to replicate (data not shown). Although vD9muD10mu formed
numerous immature and mature virions in permissive BHK-21
cells (Figure S1A), only cytoplasmic clearing, a sign of an incip-
ient virus factory, was seen in non-permissive BS-C-1 cells (Fig-
ure S1B), indicating a total block in morphogenesis.
Viral Protein Synthesis
In cells infected with VACV, viral protein synthesis is regulated:
early proteins are synthesized prior to viral DNA replication
(and in the presence of a DNA replication inhibitor such as
AraC) in relatively low amounts whereas the more abundant in-
termediate and late proteins are made exclusively post-replica-
tively. Viral proteins were analyzed to determine if impaired
synthesis could account for the block in assembly of virions in
cells infected with vD9muD10mu. BHK-21, MEF, HeLa, and
BS-C-1 cells were mock infected or infected with the panel of
mutant and WT viruses and lysates were prepared at 3, 7, 10,
and 14 hr. In parallel, cells were infected in the presence of
AraC and harvested at 14 hr. Viral proteins were analyzed by
SDS-PAGE andwestern blotting with antibody produced by rab-
bits repeatedly immunized with purified infectious VACV. For WT
VACV, vD10rev, vD9mu, and vD10mu, the viral protein patterns
were similar in each of the cell types (Figures 2A–2D). The major
bands at 7 hr and later times represent abundant post-replicative
intermediate and late proteins. Several bands representing early
proteins were seen in the 14 hr AraC samples, and faint corre-
sponding bands were seen at 3 hr in some blots (Figures 2A–
2D). Protein patterns indistinguishable from those of the WT
viruses were found in the blots of permissive BHK-21 and
MEF cells infectedwith vD9muD10mu (Figures 2A and 2B). How-
ever, in non-permissive HeLa and BS-C-1 cells infected with
vD9muD10mu, the major bands representing post-replicative
proteins were faint or undetected with the exception of a 38-
kDa species (Figures 2C and 2D). By contrast, the early proteins
made in BS-C-1 and HeLa cells infected with vD9muD10mu in
the presence of AraCwere similar to thosemade by theWT virus.
Thus, vD9muD10mu exhibited reduced post-replicative protein
synthesis in non-permissive BS-C-1 and HeLa cells.
A dynamic view of viral protein synthesis was obtained by
pulse-labeling cells with [35S]methionine and [35S]cysteine over
the course of infection and analyzing the labeled proteins by
autoradiography following SDS-PAGE. The gradual shut down
of host protein synthesis facilitates the recognition of abundant
viral proteins. BHK-21, MEF, HeLa, and BS-C-1 cells were in-
fected with the panel of WT and mutant viruses. In BHK-21
and MEF cells, a distinct viral late pattern was achieved by 9 hrst & Microbe 17, 320–331, March 11, 2015 ª2015 Elsevier Inc. 321
Figure 1. Host Restriction of Decapping
Enzyme Mutants
(A) Diagram of the D9R, D10R, and adjacent D11L
ORFs in VACV. Arrows indicate the direction of
transcription. Xs within the ORFs represent the
amino acid substitutions E129Q and E130Q for D9R
and E144Q and E145Q for D10R.
(B) Plaque formation. Viruses were grown in BHK-
21 cells and purified by sucrose gradient sedi-
mentation. BS-C-1, HeLa, MEF, and BHK-21 cells
were incubated with appropriate virus dilutions for
48 hr and then stained with a polyclonal antibody to
VACV followed by protein A conjugated to peroxi-
dase and the substrate dianisidine.
(C) One-step growth curves. BS-C-1, HeLa, MEF,
and BHK-21 cell monolayers in 12-well plates were
incubated with 5 PFU/cell of the indicated virus and
harvested at 3, 12, 24, and 36 hr. Virus titers were
determined by plaque assay in BHK-21 cells.after infection with all viruses including vD9muD10mu (Figures
3A and 3B). A prominent late pattern of viral protein synthesis
occurred in HeLa and BS-C-1 cells infected with all viruses322 Cell Host & Microbe 17, 320–331, March 11, 2015 ª2015 Elsevier Inc.except vD9muD10mu, in which the late
proteins appeared faint (Figures 3C and
3D). The western blotting and pulse-label-
ing data indicated that post-replicative
protein synthesis was severely impaired
in HeLa and BS-C-1 cells infected with
the double mutant.
Confocal microscopy was used to
investigate the formation of cytoplasmic
viral DNA factories and confirm viral
early protein synthesis using specific anti-
bodies. BS-C-1 cells were infected with
vD10rev, vD10mu, and vD9muD10mu
and fixed at 12 hr after infection. The cells
were stained with MAbs to the proteins I3,
E3, and A11 and with DAPI, which binds to
DNA in the nucleus and cytoplasmic virus
factories. I3 (Rochester and Traktman,
1998; Tseng et al., 1999) and E3 (Chang
et al., 1992) are early proteins that bind
single-stranded DNA and dsRNA, respec-
tively. A11 is a late non-structural protein
involved in viral membrane formation
(Resch et al., 2005; Yang et al., 2011). In-
fected BS-C-1 cells stained for I3, A11,
and DAPI are shown in Figure S2; staining
of E3, A11, andDAPI is shown in Figure S3.
DAPI-staining viral factories, which nor-
mally vary in number, shape, size, and
compactness, were present in cells in-
fected with each of the viruses, indicating
that vD9muD10mu was not impaired in
viral DNA synthesis. The three viral pro-
teins were mainly associated with the fac-
tories. However, whereas the two early
proteins I3 and E3 were labeled to similar
extents in the cells infected with vD10rev,vD10mu, and vD9muD10mu, there was less staining of the late
A11 protein in cells infected with the latter mutant (Figures S2
and S3). The A11 antibody staining intensity in cells infected
Figure 2. Time Course of Viral Protein Synthesis Determined by
Western Blotting
(A–D) (A) BHK-21, (B) MEF, (C) HeLa, and (D) BS-C-1 cells were mock infected
or infectedwith 5 PFU/cell of purified vD9muD10mu, vD10mu, vD9mu, andWT
virus in the absence or presence of AraC and harvested at the indicated hours
after infection. The lysates were analyzed by western blotting using rabbit
polyclonal antibody to VACV followed by secondary antibody conjugated to
peroxidase. Themass in kDa and positions of marker proteins are indicated on
the left.
Figure 3. Time Course of Protein Synthesis Determined by Pulse La-
beling with Radioactive Amino Acids
(A–D) (A) BHK-2, (B) MEF, (C) HeLa, and (D) BS-C-1 cells were mock infected
or infected with 5 PFU/cell of purified vD9muD10mu, vD10mu, vD10rev,
vD9mu, or WT virus and pulse labeled with [35S]methionine and [35S]cysteine
for 30 min at the indicated times. The cells were harvested and lysed after
pulse labeling, and the proteins were resolved by SDS-PAGE and exposed to a
PhosphorImager for visualization of newly synthesized proteins. The mass in
kDa and positions of marker proteins are indicated on the left.with vD9muD10mu, determined by a tiling procedure involving
more than 1,000 cells, was 59% to 60% of that in cells infected
with vD10rev in two separate infections. The effect of theCell Host & Microbe 17, 320–331, March 11, 2015 ª2015 Elsevier Inc. 323
Figure 4. Analysis of Viral and Cellular mRNAs and rRNAs
(A–C) BS-C-1 and BHK-21 cells were mock infected or infected with 5 PFU/cell vD9muD10mu, vD10mu, or vD10rev, and the total RNAs were isolated at the
indicated times and resolved on glyoxal gels. The RNAs were transferred to a nylon membrane; incubated with radioactive probes to the viral early C11 (A), the
viral late F17 (B), and cellular GAPDH (C) mRNAs; and visualized with a PhosphorImager.
(D) Glyoxal gels containing RNAs from BHK-21 and BS-C-1 cells that were mock infected or infected in the absence or presence of AraC for the indicated times
were stained with ethidium bromide. The RNAs were detected by fluorescence, and reverse images are shown. The size in kb and positions of size markers are
shown on the left. The major upper and lower bands represent the 28Sand 18S rRNAs, respectively.decapping enzyme mutations on A11 did not appear as severe
as for the abundant late proteins analyzed by western blotting
and pulse labeling.
mRNA Levels
Decreased viral protein synthesis could be due to a block in
translation or reduced levels of mRNA or a combination of
both. Previous studies showed that during a synchronous infec-
tion, the steady state levels of early, intermediate and late VACV
RNAs are determined by the onset of transcription as well as
degradation (Baldick and Moss, 1993). Total RNA from infected
non-permissive BS-C-1 and permissive BHK-21 cells was
resolved by electrophoresis on glyoxal gels and analyzed by
northern blotting and autoradiography. DNA probes for the viral
early transcript C11, the viral late transcript F17, and the cellular
GAPDH RNAwere prepared. The early C11mRNAwas detected
at 3 hr, peaked at 6 hr, and then gradually declined at 9 and 12 hr
in BHK-21 and BS-C-1 cells for all viruses (Figure 4A; Table S1).
However, the decrease in C11 mRNA occurred more slowly in
the cells infected with vD10mu and vD9muD10mu than with
the WT-like vD10rev. A similar result with vD10mu and a D10
deletion mutant was reported previously and interpreted as
RNA stabilization due to the absence of the D10 decapping
enzyme (Liu et al., 2014; Parrish and Moss, 2006). In the pres-
ence of AraC, which prevents synthesis of the D10 decapping324 Cell Host & Microbe 17, 320–331, March 11, 2015 ª2015 Elsevieenzyme and other post-replicative proteins, there was little
change in the amount of the C11 mRNA between 3 and 12 hr
(Figure 4A; Table S1).
Due to the requirement for viral DNA replication and intermedi-
ate gene expression, the late F17 mRNA was first detected in
significant amounts at 6 hr in BHK-21 and BS-C-1 cells and
was not found in the presence of AraC (Figure 4B; Table S1).
The F17 mRNA increased from 6 to 12 hr in BHK-21 and BS-
C-1 cells that were infected with vD10rev and vD10mu. There
was a higher amount of F17 mRNA in cells infected with
vD10mu than vD10rev as previously reported (Liu et al., 2014).
For vD9muD10mu, the pattern was very different in permissive
BHK-21 cells compared to non-permissive BS-C-1 cells. In
BHK-21 cells infected with vD9muD10mu, F17 mRNA increased
between 6 and 12 hr (Figure 4B; Table S1). In BS-C-1 cells in-
fected with vD9muD10mu, the amount of F17 mRNA was similar
to that of vD10rev and vD10mu at 6 hr, indicating that late tran-
scription was not impaired. However, the steady-state amount of
F17 mRNA sharply decreased at 9 and 12 hr (Figure 4B; Table
S1), suggesting accelerated degradation.
Cellular mRNAs are degraded in cells infected with WT VACV
(Rice and Roberts, 1983; Yang et al., 2010). At 3 and 6 hr after
infection with each of the viruses, the amount of GAPDH
mRNA was similar to the steady-state amount in mock-infected
cells (Figure 4C; Table S1). However, at 9 and 12 hr, there was anr Inc.
abrupt decline in the amounts of GAPDH mRNA, which was
more severe in BS-C-1 cells than in BHK-21 cells. The decline
occurred even with vD10rev and may be partially due to inhibi-
tion of cellular mRNA synthesis (Puckett and Moss, 1983).
Degradation of rRNA
Further analysis indicated that rRNA was degraded in BS-C-1
cells infected with vD9muD10mu. Ethidium bromide staining of
the glyoxal gels used for northern blotting demonstrated degra-
dation of both the 28S and 18S rRNA subunits in non-permissive
BS-C-1 cells that were infected with vD9muD10mu (Figure 4D).
Degradation and specific cleavage products were detectable
at 6 hr and progressed over time. There was massive rRNA
degradation at 9 hr and 12 hr (Figure 4D), correlating with the
diminution of viral late mRNA at those times in BS-C-1 cells in-
fected by vD9muD10mu. Slight rRNA degradation was also
noted in BS-C-1 cells infected with vD10mu at late times but
not with vD10rev (Figure 4D). In contrast, no rRNA degradation
was detected in permissive BHK-21 cells infected with any of
the viruses. Furthermore, rRNA degradation did not occur in
BS-C-1 cells infected in the presence of AraC (Figure 4D), indi-
cating that the trigger for rRNA degradation occurred post-repli-
catively. mRNA and rRNA degradation and the accumulation of
rRNA cleavage products are signatures of the activation of
RNase L, a single-strand-specific endonuclease that is usually
present in an inactive state (Silverman, 2007). RNase L is acti-
vated by 2050-oligoadenylates (2-5A) synthesized by 2050-oligoa-
denylate synthetase (OAS). OAS activity depends on interaction
with dsRNA, which increases post-replicatively in cells infected
with VACV as shown below.
An A549 human alveolar epithelial cell line stably transfected
with shRNase L (S. Banerjee, A. Chakrabarti and R.H. Silverman,
personal communication) was used to confirm that rRNA break-
downwas due to RNase L. The extent of RNase L knock-down is
shown in Figure S4A. The shControl and shRNaseL cells were
mock infected or infected with vD10rev, vD9muD10mu, or an
E3 deletion mutant (vDE3L) for 14 hr in the presence or absence
of AraC. The vDE3L was used as a positive control since the
mutant is susceptible to RNase L activation (Xiang et al., 2002).
Cleavage of 28S and 18S RNA occurred in the A549 control cells
infected with the three strains of VACV but was greatest in
the vD9muD10mu and vDE3L mutants (Figure S4B). However,
much less rRNA degradation occurred in the shRNaseL A549
cells (Figure S4B), confirming that the virus-induced degradation
was RNaseL mediated. Nevertheless, the knockdown of RNase
L was insufficient to confer replication of either vD9muD10mu or
vDE3L (data not shown).
Accumulation of dsRNA
To determine whether the accumulation of dsRNA correlated
with rRNA cleavage, we used the well-characterized J2 mAb
that is specific for dsRNA of at least 40 bp (Bonin et al., 2000;
Marshall et al., 2009; Scho¨nborn et al., 1991; Targett-Adams
et al., 2008) and has been reported to detect dsRNA in cells in-
fected with VACV (Weber et al., 2006; Willis et al., 2011). BS-
C-1 cells were infected with vD10rev, vD9mu, vD10mu, and
vD9muD10mu and fixed at 8 and 12 hr after infection. The cells
were stained with the dsRNA-specific J2 mAb; DAPI was used
to visualize DNA in the nucleus and virus factories in the cyto-Cell Hoplasm. Nearly all cells infected with vD9muD10mu exhibited
bright dsRNA-staining at 12 hr, which at higher magnification
appeared to be associated with factories (Figure 5A). There
were few bright dsRNA-staining cells infected with vD10mu,
only occasional bright dsRNA-staining cells infected with vD9
or vD10rev, and only dim staining of uninfected cells (Figure 5A).
Co-staining with antibody to the viral A11 protein was used
to verify the completeness of the infections with vD10rev,
vD10mu, and vD9muD10mu (not shown).
The relative amounts of dsRNA were calculated from the fluo-
rescence intensity, which was determined using Imaris image
processing software. The strongest signals were obtained from
cells infected with vD9muD10mu, and this increased from 8 to
12 hr to a level of 100-fold more than in uninfected cells,
15-fold higher than in cells infected with vD10rev, and
7-fold higher than in cells infected with vD10mu (Figure 5B).
Addition of the DNA replication inhibitor AraC, which blocks
the formation of large amounts of complementary VACV RNA
(Boone et al., 1979) and prevented the breakdown of rRNA in
BS-C-1 cells infected with vD9muD10mu (Figure 4D), also pre-
vented the increase in dsRNA (Figure S5). Thus, the degradation
of mRNA and rRNA in cells infected with vD9muD10mu corre-
lated with greatly increased dsRNA.
Phosphorylation of PKR, eIF2a, and IRF3
In addition to activating OAS and RNase L, dsRNA induces the
phosphorylation of PKR, which phosphorylates the translation
initiation factor eIF2a (DeWitte-Orr and Mossman, 2010). BS-
C-1 cells infected with vD9muD10mu induced strong phosphor-
ylation of PKR and eIF2a by 7 hr, whereas phosphorylation of
these proteins occurred later following vD10mu infection and
was minimal with vD10rev (Figures 6A and 6B). Moreover, phos-
phorylation of PKR and eIF2a was almost completely prevented
by AraC (Figures 6A and 6B). Similarly, IRF3 was phosphorylated
by 10 hr in BS-C-1 cells infected with vD9muD10mu, whereas
phosphorylation occurred later and to a lesser extent following
infection with vD10mu and was undetectable with vD10rev or
vD9mu (Figure 6C). AraC also prevented phosphorylation of
IRF3 (Figure 6C).
Attenuation of the vD9muD10mu in Mice
Wepreviously reported that vD10muwasmodestly attenuated in
mice, even though it replicated well in MEFs (Liu et al., 2014). It
was therefore of interest to determine the degree of attenuation
of vD9muD10mu, which also replicated in MEFs. The Western
Reserve (WR) strain of VACV, used as the parent virus to
construct the decapping mutants, is highly pathogenic for
BALB/c mice inoculated by the intranasal route (Law et al.,
2005;Williamson et al., 1990). Virus spread with the highest titers
in the nasal turbinates and lungs accompanies weight loss; the
LD50 is approximately 5 3 10
4 PFU for the WR strain. In the pre-
sent study, 6-week-old BALB/c mice were infected intranasally
with several doses of WT, vD10rev, vD9mu, vD10mu, and
vD9muD10mu. The mice were inspected for signs of morbidity
and weighed daily. According to NIH protocols, mice that lose
30% of their weight must be euthanized. At the 105 PFU chal-
lenge dose, severe weight loss and deaths occurred with the
WT, vD10rev, and vD9mu but not with vD10mu or vD9muD10mu
(Figure 7A, left panel). At the 106 PFU dose, the mice infectedst & Microbe 17, 320–331, March 11, 2015 ª2015 Elsevier Inc. 325
Figure 5. Confocal Microscopic Imaging of
dsRNA
BS-C-1 cells were infected with 5 PFU/cell of
vD10rev, vD9mu, vD10mu, or vD9muD10mu. At 8
and 12 hr after infection, the cells were fixed and
stained with the J2mousemAb specific for dsRNA
followed by conjugated anti-mouse antibody and
DAPI.
(A) Representative images are shown. dsRNA:
green; DNA: red.
(B) Fluorescence intensity per cell was determined
using Imaris imaging software. Cumulative in-
tensity was calculated automatically for 50 tiles
containing approximately 1,200 to 4,500 cells.
After normalization for the number of cells in the
different samples, the data were plotted as the
average mean fluorescence intensity.with vD10mu also showed severe weight loss and one
death, whereas still no weight loss or death occurred with
vD9muD10mu (Figure 7A, right panel), indicating extreme
attenuation.
To further investigate the attenuation of vD9muD10mu, the
amounts of virus in nasal turbinates and lungs at days 3, 6, and
9 were determined following challenge with non-lethal doses of
vD9muD10mu, vD10mu, vD9mu, and vD10rev (Figure 7B). At
both 105 and 106 PFU challenge doses of vD9muD10mu, the vi-
rus titers in the nasal turbinates and lungs were significantly less
than that obtained after infection with 105 PFU of vD10rev and
vD9mu (p % 0.0007, Mann-Whitney test on combined titers for
days 3, 6, and 9). In addition, there was significantly less virus
in the turbinates and lungs of mice infected with 105 PFU of
vD9muD10mu compared to 105 PFU of vD10mu (p < 0.005)326 Cell Host & Microbe 17, 320–331, March 11, 2015 ª2015 Elsevier Inc.and 106 PFU of vD9muD10mu compared
to 106 PFU of vD10mu (p% 0.0003). Very
little vD9muD10mu was recovered from
the other organs (spleen, liver, and
ovaries) at either challenge dose of
vD9muD10mu (not shown).
The VACV antibody titers, determined
on pooled sera from surviving mice at
3 weeks after intranasal infection (Fig-
ure S6A), correlated directly with the
extent of virus spread (Figure 7B). The
antibody titers of mice were 105 PFU
vD9muD10mu<106PFUvD9muD10mu<
105 PFU vD10mu < 106 PFU vD10mu =
105 PFU vD10rev. Nevertheless, the im-
mune responses of even the highly atten-
uated vD9muD10mu virus were sufficient
to protect mice against a lethal challenge
with pathogenic VACV (Figure S6B).
DISCUSSION
dsRNA has been considered to be the
most important viral pathogen-associ-
ated molecular pattern (DeWitte-Orr and
Mossman, 2010; Silverman, 2007).Nevertheless, dsRNA is produced during replication of most
RNA and DNA viruses. For dsDNA viruses, complementary
RNA can arise by convergent transcription from opposite DNA
strands and in the case of VACV is exacerbated by inefficient
transcription termination at post-replicative times. Approxi-
mately 15% of the polyadenylated RNA synthesized at interme-
diate and late times of VACV replication can anneal to form long
intermolecular duplexes with single-stranded tails, whereas very
little complementary RNA is made at early times or when AraC
inhibits viral DNA replication (Boone et al., 1979). Hybridization
studies indicated that the complementary sequence mapped
to numerous genes along the genome (Boone et al., 1979), which
was confirmed recently by RNA-seq (Yang et al., 2010). Some of
the complementary RNA made at late times appears to exist in a
double-stranded form when isolated directly from cells omitting
Figure 6. Phosphorylation of PKR, eIF2a,
and IRF3
BS-C-1 cells were mock-infected or infected with
vD10rev, vD10mu, vD9mu, and vD9muD10mu in
the absence or presence of AraC. At indicated
hours the cells were lysed, and the lysates were
analyzed by western blotting with rabbit MAbs to
phosphorylated PKR (p-PKR), eIF2a, phosphory-
lated eIF2a (p-eIF2a), IRF3, phosphorylated IRF3
(p-IRF3), and rabbit polyclonal antibody to actin
followed by secondary antibody conjugated to
peroxidase.phenol extraction (Colby andDuesberg, 1969). Cytoplasmic sen-
sors of dsRNA include PKR, OAS, RIG-1, MDA5, and NALP3,
and more may await discovery (DeWitte-Orr and Mossman,
2010). Activation of these sensors generally leads to suppression
of virus replication: PKR inhibits translation by phosphorylation
of the translation initiation factor eIF2a and has additional anti-
viral activities; OAS synthesizes 2-5A oligonucleotides that acti-
vate RNase L, which cleaves single stranded RNAs including
mRNA and rRNA; RIG-1 and MDA5 recruit IPS-1 resulting in
phosphorylation of IRF3 and induction of interferon and NALP-
3 inducing inflammasome formation. Here we provide evidence
that an important biological role of the VACV decapping en-
zymes is to prevent accumulation of dsRNA and the subsequent
activation of antiviral responses.
RNA-seq studies demonstrated accelerated decay of thou-
sands of host mRNAs including those involved in innate im-
mune responses by 4 hr after infection with VACV, suggesting
that the decapping enzymes may contribute to protection
against host anti-viral responses (Yang et al., 2010). By accel-
erating decay of viral mRNAs, the decapping enzymes may
also sharpen the transition between early, intermediate, and
late stages of infection. To further investigate the roles of the
VACV decapping enzymes, we made point mutations that
were previously shown to specifically and completely inactivate
catalytic activity of both D9 and D10 in vitro (Parrish and Moss,
2007; Parrish et al., 2007) without perturbing neighboringCell Host & Microbe 17, 320–33genes. Inactivation of the D9 decapping
enzyme had no effect on virus replica-
tion, and mutation of D10 had only a
modest deleterious effect, whereas mu-
tation of both drastically reduced repli-
cation in monkey and human cells and
caused extreme attenuation in a murine
respiratory infection model. The severe
phenotype resulting from inactivation of
both decapping enzymes indicated that
they compensate for each other, consis-
tent with their similar decapping activ-
ities in vitro (Parrish and Moss, 2006,
2007). Since inactivation of D10 alone
increased mRNA stability (Liu et al.,
2014), we had anticipated that inactiva-
tion of both decapping enzymes would
increase stability even more. However,
because our mutant still contains theE3 dsRNA binding protein, we did not anticipate that increased
late complementary RNA would trigger a potent dsRNA
response. Therefore, it was surprising to find drastic inhibition
of protein synthesis and virtually complete loss of mRNA and
intact rRNA in cells infected with the double mutant. Further
studies revealed that this phenotype correlated with a huge in-
crease in dsRNA, activation of RNase L, and phosphorylation of
PKR, eIF2a, and IRF3. Very little dsRNA was present in BS-C-1
cells infected with WT revertant virus or the D9 mutant consis-
tent with the absence of PKR phosphorylation and rRNA degra-
dation. More dsRNA accumulated in cells infected with the D10
mutant, but this was still much less than with the double
mutant, and PKR phosphorylation was delayed, and only slight
degradation of rRNA was noted. The dsRNA evidently formed
from viral RNA since: (i) dsRNA was not reliably detected in
uninfected cells; (ii) dsRNA increased from 8 to 12 hr after
infection with vD9muD10mu, which correlated with the time
of synthesis of complementary viral mRNA during infection
with VACV (Boone et al., 1979); (iii) AraC, which prevents syn-
thesis of post-replicative viral complementary RNAs, prevented
accumulation of dsRNA and rRNA breakdown mediated by
RNase L activation; and (iv) dsRNA localized to virus factories,
the site of viral intermediate and late transcription. Increased 2-
5A, the product of OAS, was previously shown to increase dur-
ing WT VACV infection, but rRNA cleavage was delayed (Rice
et al., 1984); the kinetics of formation and inhibition by AraC1, March 11, 2015 ª2015 Elsevier Inc. 327
Figure 7. Effect of D9 and D10Mutations on
Virulence in Mice
(A) Weight loss. BALB/c mice in groups of five
were infected intranasally with 105 or 106 PFU
of WT VACV, vD10rev, vD10mu, vD9mu, or
vD9muD10mu. The mice were weighed daily and
euthanized if their weight dropped by 30%. As-
terisks indicate day of death or euthanasia of in-
dividual mice. Bars indicate SEM.
(B) Organ titers. BALB/c mice in groups of four
were infected intransally with 105 or 106 PFU of
vD10mu or vD9muD10mu or 105 PFU vD10rev or
vD9mu. On the days indicated, the turbinates and
lungs of individual mice were homogenized and
the virus titers determined by plaque assay on
BHK-21 cells. Bars indicate SEM.led those authors to suggest that dsRNA derived from late
complementary sequences was responsible. Activation of the
RNase L pathway was previously described for a VACV tem-
perature-sensitive A18 DNA helicase mutant, which was attrib-
uted to increased dsRNA resulting from failure to control the
length of late transcripts (Bayliss and Condit, 1993, 1995;
Simpson and Condit, 1994, 1995). Some increased dsRNA
has also been reported for a K1L deletion mutant, although
the mechanism remains to be determined (Willis et al., 2011).
RNAs decapped by D9 and D10 have 50 monophosphate ends
making them susceptible to 50 exonuclease digestion (Parrish
and Moss, 2007; Parrish et al., 2007). Although VACV does not
appear to encode a RNA 50 exonuclease, a human genome-
wide siRNA screen indicated the importance of Xrn1, the major
cytoplasmic RNA 50 exonuclease, for VACV replication and
spread (Sivan et al., 2013). Moreover, in the accompanying
report Burgess and Mohr (2015) confirm the inhibition of VACV
replication by Xrn1 knockdown and further demonstrate the
accumulation of dsRNA and phosphorylation of PKR and
eIF2a. Thus it is likely that D9 and D10 act coordinately with
Xrn1 to mediate mRNA decay and prevent accumulation of
dsRNA. However, whether these activities reduce the annealing
of complementary RNA or degrade dsRNA remains to be deter-
mined.With regard to the latter, there is evidence that Xrn1 asso-
ciates with other proteins including a helicase that could help
unwind dsRNA and allow degradation (Jones et al., 2012). Xrn1
also associates with the cytoplasmic DCP1/DCP2 decapping
complex, but evidently, the host enzymes are unable to compen-
sate for loss of D9 and D10 during VACV infection.328 Cell Host & Microbe 17, 320–331, March 11, 2015 ª2015 Elsevier Inc.Poxviruses encode several early pro-
teins that prevent the cell from recog-
nizing or responding to dsRNA. The E3
protein encoded by VACV binds and
sequesters dsRNA (Chang and Jacobs,
1993; Chang et al., 1992), and the K3 pro-
tein inhibits eIF2a phosphorylation by
PKR (Carroll et al., 1993; Davies et al.,
1992). The K1 protein has recently been
reported to reduce the amount of dsRNA
(Willis et al., 2011). We demonstrated that
E3 was expressed in cells infected with
vD9muD10mu, but apparently the proteinwas overwhelmed by the huge amounts of dsRNA that accumu-
lated in the absence of the viral decapping enzymes. Although
the mechanism by which binding of E3 to dsRNA prevents
activation of the innate immune pathways is not known, stoi-
chiometric amounts are presumably needed. Therefore, the
phenotype of vD9muD10mu might be reversed by greatly over-
expressing E3 before dsRNA accumulates. We have moderately
overexpressed E3 by transfection, but only a slight increase in
viral protein synthesis and plaque size was observed (R.L.,
unpublished data). Further efforts will be made to more highly
overexpress E3.
It makes sense that the host range restriction of the VACV de-
capping mutant is similar to that previously described for a dele-
tion mutant of the E3 dsRNA binding protein (i.e., chick embryo
fibroblasts, rabbit kidney-13, and hamster BHK-21 cells are
permissive, and African green monkey cells and human HeLa
cells are non-permissive) (Beattie et al., 1996; Langland and Ja-
cobs, 2002; Xiang et al., 2002). In future experiments, we will
address the question of how certain cells can support replication
of the VACV double decapping enzyme mutant without causing
degradation of RNA or inhibition of viral protein synthesis. Sus-
ceptibility may be related to the endogenous levels of dsRNA
sensors, since activation of antiviral pathways depends on their
levels in addition to dsRNA. For example, cells with lower levels
of OAS are more resistant to dsRNA (Stark et al., 1979; Zhao
et al., 2013). On the other hand, mouse macrophages have
high levels of OAS (Zhao et al., 2013), and this may contribute
to the severe attenuation of vD9muD10mu seen after intranasal
infection of mice compared to MEFs. In addition, since OAS
and PKR are interferon inducible, interferons could also con-
tribute to attenuation in mice, while the replication of
vD9muD10mu was not impaired in MEF cells. We plan to further
study the relationship between specific dsRNA sensors and host
restriction of vD9muD10mu in cells and animals.
EXPERIMENTAL PROCEDURES
Cells and Viruses
BS-C-1, HeLa, RK-13, andBHK-21 cells were grown inminimum essential me-
dium with Earle’s balanced Salts supplemented with 2 mM L-glutamine, 100
units penicillin, and 100 mg streptomycin per ml (Quality Biological, Inc.) and
containing 8% fetal bovine serum (FBS) (Sigma-Aldrich). C57BL/6 MEFs
(ATCC SCRC-1008) were grown in Dulbecco’s modified eagle’s medium
(Quality Biological, Inc.) supplemented with 4 mM L-glutamine, 20% FBS,
100 units penicillin, and 100 mg streptomycin per ml.
Construction of Recombinant Viruses
VACV recombinants were derived from the WR strain of VACV (ATCC VR-
1354). vD10mu, with catalytic site mutations E144Q and E145Q and the WT
vD10rev viruses were described (Liu et al., 2014). The D9 mutant vD9mu
was constructed by replacing the EGFP ORF in vDD9 (Parrish and Moss,
2006) with a D9R ORF containing the catalytic site mutations E129Q and
E130Q. The vD9muD10mu double mutant was generated in two steps: homol-
ogous recombination was used to replace the D9 ORF of vD10mu with the
EGFP ORF; second, the EGFP ORF was replaced by the D9 ORF with active
site mutations E129Q and E130Q. Plaques were picked under a fluorescent
microscope and clonally purified. The modified regions of the recombinant vi-
ruses were PCR amplified and sequenced.
Virus Purification
Recombinant viruses, grown in BHK-21 cells, were purified by centrifugation
through a 36% sucrose cushion followed by centrifugation through a 24%–
40% sucrose gradient as described (Liu et al., 2014). BHK-21 cells were
used for plaque assay to determine infectivity.
Western Blotting
Western blotting was carried out by electrophoresis on 4%–12%NuPAGEBis-
Tris gels (Life Technologies) and transfer to a nitrocellulose membrane with an
iBlot system (Life Technologies). The membrane was blocked in 5% non-fat
milk in PBSwith 0.05% tween-20 (PBST) for 1 hr, washedwith PBST, and incu-
bated with the primary antibody in PBST containing 5% non-fat milk for 1 hr.
The membrane was washed with PBST and incubated with the secondary
antibody conjugated by horseradish peroxidase in PBST with 5% non-fat
milk for 1 hr. After washing the membrane, the amount of protein bound by
the secondary antibody was visualized by SuperSignal West Femto substrates
(Thermo Scientific). Antibodies are described in Supplemental Experimental
Procedures. In Figure 6C, cells were lysed with buffer containing phosphatase
inhibitors as follow: 1 mM sodium orthovanadate (Fisher), 2 mM sodium pyro-
phosphate (Sigma-Aldrich), 50mMglycerol-2-phosphate disodium (Sigma-Al-
drich), and 50 mM sodium fluoride (Sigma-Aldrich).
Pulse-Labeling Proteins
Cells on 12-well plates were infected with 5 PFU/cell of VACV. After 1.5 hr,
the cells were washed and incubated with fresh medium. At intervals, the
medium was replaced with methionine- and cysteine-free RPMI 1640
(Sigma-Aldrich) containing 2.5% dialyzed FBS (Hyclone); after 30 min, the
medium was replaced with fresh methionine- and cysteine-free RPMI 1640
containing 100 mCi/ml of [35S]methionine and [35S]cysteine (Perkin Elmer)
for 30 min. Cells were harvested, washed, and lysed in buffer containing
10 mM Tris (pH 7.5), 10 mM NaCl, 2 mM CaCl2, 0.5% NP-40, and 1 X
EDTA-free protease inhibitors (Roche), in the presence of 1,000 gel units of
micrococcal nuclease (New England Biolabs) at room temperature for
15 min. Lithium dodecyl sulfate sample and reducing buffers (1 X NuPAGE;
Life Technologies) were added to the lysates, followed by heating at 70C
for 15 min. Proteins were resolved on 4%–12% NuPAGE Bis-Tris gels (Life
Technologies), dried on Whatmann paper, and exposed to a PhosphorIm-Cell Hoager screen and visualized by a Molecular Dynamics Typhoon 9410 Molec-
ular Imager (GE Amersham).
Analysis of RNA by Northern Blotting
Total RNA was isolated using RNeasy mini kit (QIAGEN), resolved by electro-
phoresis on a glyoxal gel (Life Technologies), and electrophoretically trans-
ferred to a nylon membrane (Liu et al., 2014). DNA probes labeled with
[a-32P]dCTP (Perkin Elmer) were made with a Decaprime II random priming
kit (Life Technologies) using a 300–400 nt PCR fragment amplified from the
gene of interest. The probed membrane was exposed to a PhosphorImager
screen as above. Quantitation was performed with GelEval 1.35 (FrogDance
software; http://www.frogdance.dundee.ac.uk).
Analysis of dsRNA by Confocal Microscopy
BS-C-1 cells were mock-infected or infected with 5 PFU/cell of virus for 8 and
12 hr, after which the cells were fixed and stained essentially as described
above. The J2 mAb (SCICONS, Szirak, Hungary) was diluted 1:100 and incu-
bated with the cells overnight. After washing, secondary anti-mouse Alexa
Fluor 488 was applied at a 1:100 dilution for 6 hr. Nuclei were stained with
DAPI as above. Confocal images were collected using a Leica DMI6000
confocal microscope enabled with 403 or 633 oil immersion objective with
a NA of 1.32 and 1.4, respectively. Images were acquired using constant laser
intensity for Argon Laser and 488 nm wavelength for Alexa 488 excitation,
and photons were collected using constant photomultiplier electronic gain
between the samples to quantify the differences in absolute intensity levels.
Images were collected and processed using Imaris 7.1 (Bitplane AG, Zurich)
and Adobe Photoshop CS3 (Adobe Systems, San Jose) to adjust brightness.
For quantification, images were collected using an automated tiling method to
obtain an unbiased data pool from 50 to 100 tiles. Acquired images were
further analyzed using Imaris image processing software to calculate the abso-
lute total intensity per cell. Cumulative intensities were plotted as average
mean intensity normalized to the uninfected sample.
Determination of Virulence in Mice
Animal study protocols were approved by the National Institute of Allergy and
Infectious Diseases Animal Care and Use Committee. The virulence of re-
combinant viruses was determined following intranasal inoculation by
comparing the weight loss and viral titers in the organs as previously
described (Liu et al., 2014). Mice were euthanized when they lost 30% of
their original weight. Mann-Whitney test was employed to determine signifi-
cance of differences in virus titers of lungs and turbinates. Statistical ana-
lyses were performed with GraphPad Prism version 6.00 (GraphPad Soft-
ware, La Jolla).
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